Inj pitocin use
I'll check the medical library skill first, then look up Pitocin (oxytocin) comprehensively.
Reading File
Now let me search the library and PubMed in parallel for Pitocin (oxytocin) injection.
Finding Sources
Searching PubMed
oxytocin labor induction uterotonic
Good results. Now let me read the most relevant sections in parallel - Goodman & Gilman (pharmacology), Morgan & Mikhail (anesthesiology), and Creasy & Resnik (obstetrics).
Reading File
Reading File
Reading File
Excellent - rich data from three authoritative sources. Let me now compile the full answer.
Injection Pitocin (Oxytocin) - Complete Clinical Guide
What is it?
Pitocin is the brand name for synthetic oxytocin, a nonapeptide identical to the endogenous posterior pituitary hormone. It is available as an injectable solution (10 U/mL) given by IV infusion or IM injection.
Mechanism of Action
Oxytocin acts on specific G-protein coupled receptors (OTRs) on uterine myometrial cells. Receptor binding triggers:
- Increased intracellular calcium - direct smooth muscle contraction
- Sensitization of the myometrium to estrogen (estrogen up-regulates OTRs near term)
- Stimulation of prostaglandin synthesis, which amplifies contractions
At high doses, oxytocin also activates vasopressin V2 receptors, causing antidiuretic (water-retaining) effects.
Indications
| Indication | Detail |
|---|---|
| Induction of labor | When risk of continued pregnancy > risk of induction (e.g., post-dates, IUGR, pre-eclampsia, PROM) - requires a ripened cervix |
| Augmentation of labor | When spontaneous labor is inadequately progressing (hypotonic contractions) |
| Prevention of PPH | Administered immediately after delivery of the placenta - standard of care |
| Treatment of uterine atony/PPH | First-line uterotonic for postpartum hemorrhage |
| Milk ejection | Oxytocin nasal spray used off-label; parenteral form not for this |
Important FDA note: Pitocin is NOT indicated for elective induction of labor (i.e., induction with no medical indication). The available data are considered inadequate to justify the benefit-to-risk ratio for elective use.
- Goodman & Gilman's Pharmacological Basis of Therapeutics
Dosing Protocols
Labor Induction/Augmentation (IV Infusion only)
| Protocol | Starting Dose | Increments | Notes |
|---|---|---|---|
| Low-dose | 0.5 - 2 mU/min | Increase every 30-40 min | Preferred; lower hyperstimulation risk |
| High-dose | 6 mU/min | Increase every 15-40 min | Faster effect; higher hyperstimulation risk |
| Typical range | Up to 8 mU/min (some protocols up to 20-40 mU/min) | Titrate to 3 contractions/10 min | Stop if fetal distress appears |
Half-life: 3-15 minutes (variously reported as 3-5 min clinically; 12-15 min to steady state). Steady-state uterine response achieved in ~30 minutes.
Postpartum Hemorrhage Prevention/Treatment
| Route | Dose | Preparation |
|---|---|---|
| IV infusion (preferred) | 20-50 U in 1 L NS/LR | Run at rate sufficient to maintain uterine tone |
| IM | 10 U | Single injection after delivery |
| IV bolus | AVOID - causes hypotension | Use controlled infusion instead |
- Creasy & Resnik's Maternal-Fetal Medicine and Morgan & Mikhail's Clinical Anesthesiology
Side Effects and Complications
Maternal
| Effect | Mechanism | Clinical Significance |
|---|---|---|
| Hypotension | Relaxation of vascular smooth muscle (vasodilation) | Especially with rapid IV bolus; may be severe |
| Reflex tachycardia | Baroreceptor response to hypotension | Usually transient |
| Water intoxication / Hyponatremia | V2 receptor activation - antidiuretic effect | Prolonged high-dose infusion; can cause seizures |
| Uterine hyperstimulation | Excessive contractions (>5 in 10 min) | Fetal distress, placental abruption |
| Uterine tetany | Sustained, non-relaxing contraction | Fetal asphyxia; requires immediate cessation |
| Nausea/Vomiting | Central effect | Less common |
Fetal
- Fetal distress (non-reassuring FHR) due to hyperstimulation and reduced uteroplacental perfusion
- Fetal bradycardia from tetanic contractions
Deep/general anesthesia can exaggerate oxytocin's hypotensive effect by blunting the reflex tachycardia compensation. Volatile agents should be reduced to 0.5 MAC in obstetric patients under GA.
- Morgan & Mikhail's Clinical Anesthesiology, 7e
Contraindications
- Elective induction (no medical indication)
- Cephalopelvic disproportion (CPD) - significant or absolute
- Unfavorable fetal position that cannot be corrected prior to delivery
- Obstetric emergencies requiring immediate surgical delivery
- Placenta previa or vasa previa
- Prior classical (vertical) uterine incision or other uterine surgery with risk of rupture
- Active herpes genitalis (if vaginal delivery contraindicated)
- Fetal distress where delivery is not imminent
Important Drug Interactions & Precautions
- Cyclopropane anesthesia - may cause maternal sinus bradycardia and abnormal AV rhythms; concurrent use with vasopressors can cause severe hypertension
- Vasopressors - enhanced pressor effect; monitor blood pressure closely
- Excessive antidiuretic effect at high doses - monitor fluid balance and serum sodium with prolonged infusions
Second-Line Uterotonics (If Pitocin Fails)
When oxytocin alone doesn't control uterine atony:
| Drug | Dose | Notes |
|---|---|---|
| Methylergonovine (Methergine) | 0.2 mg IM | Contraindicated in hypertension; never IV bolus |
| Carboprost tromethamine (Hemabate) | 0.25 mg IM q15-90 min (max 2 mg) | Contraindicated in asthma; causes bronchoconstriction |
| Misoprostol (PGE1) | 600-1000 mcg rectal/sublingual | No refrigeration needed; good resource-limited settings |
| Tranexamic acid | 1 g IV | Added for hemorrhage management (WOMAN trial) |
Key Clinical Pearls
- Always give by IV infusion, never rapid IV bolus for uterine atony - bolus causes acute vasodilation and dangerous hypotension.
- Continuous electronic fetal monitoring is mandatory during oxytocin infusion.
- Stop the infusion immediately if: fetal distress, uterine hyperstimulation (tachysystole), or tetanic contraction occurs.
- Oxytocin is on the "high-alert medication" list (ISMP) due to its potential for serious harm when used in error.
- Cervical ripening with prostaglandins (dinoprostone/misoprostol) should precede oxytocin induction when the cervix is unfavorable (Bishop score < 6).
- The antidiuretic effect at high doses is clinically significant - hyponatremia can cause maternal seizures; restrict hypotonic fluids.
Sources:
- Goodman & Gilman's Pharmacological Basis of Therapeutics, 14e - Clinical Use of Oxytocin
- Morgan & Mikhail's Clinical Anesthesiology, 7e - Obstetric Pharmacology
- Creasy & Resnik's Maternal-Fetal Medicine - Table of Oxytocic Medications
- Tietz Textbook of Laboratory Medicine, 7e - Oxytocin Physiology
This is a shared conversation. Sign in to Orris to start your own chat.